Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
The Male Cancer Screening Panel evaluates critical biomarkers linked to prostate, liver, testicular, and gastrointestinal cancers. This panel is ideal for men seeking early detection, routine monitoring, or reassurance about cancer risk.
Prostate-Specific Antigen (PSA): Evaluates prostate health and can indicate early signs of prostate cancer or benign conditions
Alpha-Fetoprotein (AFP): Monitors liver function and certain testicular tumours
Carcinoembryonic Antigen (CEA): Helps detect and monitor gastrointestinal and other epithelial cancers
CA 19-9: Assesses potential pancreatic and gastrointestinal tract abnormalities
Service Information:
All samples are tested in CQC-regulated, UKAS-accredited laboratories. Includes mobile sample collection from your location and a comprehensive doctor review and analysis of your results.
The Male Cancer Screening Panel evaluates critical biomarkers linked to prostate, liver, testicular, and gastrointestinal cancers. This panel is ideal for men seeking early detection, routine monitoring, or reassurance about cancer risk.
Prostate-Specific Antigen (PSA): Evaluates prostate health and can indicate early signs of prostate cancer or benign conditions
Alpha-Fetoprotein (AFP): Monitors liver function and certain testicular tumours
Carcinoembryonic Antigen (CEA): Helps detect and monitor gastrointestinal and other epithelial cancers
CA 19-9: Assesses potential pancreatic and gastrointestinal tract abnormalities
Service Information:
All samples are tested in CQC-regulated, UKAS-accredited laboratories. Includes mobile sample collection from your location and a comprehensive doctor review and analysis of your results.